N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups and Individualized Services

Sponsor: University of Oregon • ClinicalTrials.gov ID: NCT07529327

Registry updated: 2026-10-13
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

The goal of this clinical trial is to test ways to improve early language development among young children of parents with substance use disorder (SUD). Children of parents with SUD are at increased risk for language delays, and early supports may help prevent long-term learning challenges. This study will examine whether adding additional supports to group-based parenting intervention improves child language outcomes compared to the group intervention alone.

Interventions

  • Comilia Group (Behavioral)
    Parents participate in six weekly 90-minute in-person groups led by a trained facilitator and offered in English or Spanish. Groups use modeled caregiver-child interaction videos and guided discussion to teach evidence-based communication strategies.
  • Interaction Review Enhancement (Behavioral)
    Parents receive three one-hour telehealth coaching sessions with a licensed speech-language pathologist to review caregiver-child interactions, practice communication strategies, and receive individualized feedback.
  • Practical Support Enhancement (Behavioral)
    Participants receive three one-hour telehealth sessions focused on identifying barriers to using the communication strategies introduced in the group sessions. Interventionists work with parents to develop structured supports (e.g., mindfulness tools, visual aids, tracking logs, timers) and set goals to address planning, attention, or memory challenges that may interfere with implementation.

Eligibility criteria

Inclusion Criteria: 1. Have a: 1. Self-reported lifetime history of substance use disorder treatment and/or 2. active substance use in the past year 2. Be providing care for/parenting a child at least 10% of the time who is: 1. between the ages of 12-42 months 2. English/Spanish bilingual or monolingual in English or Spanish 3. exposed to a third language once a week or less 4. not yet combining three or more words regularly 5. has less than 150 words in their expressive vocabulary 3. Be able to provide consent for their target child to participate, or have a legal guardian provide consent for the child to participate 4. Be able to speak and understand English and/or Spanish 5. Be willing to attend groups once a week for six weeks at a participating site/group time 6. If assigned additional services, willing to attend virtual meetings 7. Be 18 years of age or older Exclusion Criteria: -Only one caregiver per focal child can participate in the research study. Caregivers whose participating child already has another caregiver enrolled in the research study will not be eligible to participate.

Conditions

Language Delay Substance Use Disorders Language Disorders in Children Language Development Prevention Intervention

Locations

  • Prevention Science Institute — Eugene, Oregon, United States
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record